Basit öğe kaydını göster

Fixed drug eruption induced by trimethoprim-sulfamethoxazole: evidence for a link to HLA-A30 B13 Cw6 haplotype.

dc.contributor.authorAkar, U
dc.contributor.authorOzkaya-Bayazit, Esen
dc.date.accessioned2021-03-03T14:32:31Z
dc.date.available2021-03-03T14:32:31Z
dc.date.issued2001
dc.identifier.citationOzkaya-Bayazit E., Akar U., "Fixed drug eruption induced by trimethoprim-sulfamethoxazole: evidence for a link to HLA-A30 B13 Cw6 haplotype.", Journal of the American Academy of Dermatology, cilt.45, sa.5, ss.712-7, 2001
dc.identifier.issn0190-9622
dc.identifier.othervv_1032021
dc.identifier.otherav_3a240627-16d7-4530-9027-f12e5d08fc57
dc.identifier.urihttp://hdl.handle.net/20.500.12627/43062
dc.identifier.urihttps://doi.org/10.1067/mjd.2001.117854
dc.description.abstractBackground. Recent reports indicated a significant association between fixed drug eruption (FDE) and HLA class I antigens. A strong correlation was found between B22 antigen and feprazone-induced FDE.
dc.language.isoeng
dc.subjectKlinik Tıp (MED)
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectDermatoloji
dc.subjectKlinik Tıp
dc.subjectDERMATOLOJİ
dc.subjectTıp
dc.titleFixed drug eruption induced by trimethoprim-sulfamethoxazole: evidence for a link to HLA-A30 B13 Cw6 haplotype.
dc.typeMakale
dc.relation.journalJournal of the American Academy of Dermatology
dc.contributor.department, ,
dc.identifier.volume45
dc.identifier.issue5
dc.identifier.startpage712
dc.identifier.endpage7
dc.contributor.firstauthorID163440


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster